Skip to content

Innoviva, Inc. INVA Change in AR

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Merck & Co. logo
Merck & Co.MRK
$272.5M+347%
AbbVie logo
AbbVieABBV
-$87M-106%
Insmed logo
InsmedINSM
$38.19M+812%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$6.41M-1,213%
Organon logo
OrganonOGN
$65M-23.5%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s change in AR?
Innoviva, Inc. (INVA) reported change in AR of -$961K in Q1 2026.
How has Innoviva, Inc.'s change in AR changed year-over-year?
Innoviva, Inc.'s change in AR increased by 74.2% year-over-year, from -$3.72M to -$961K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.